 (OTC:OLOXF) Stock, Quote.Headers.trade-ideas

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Ciena Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) to report quarterly earnings at 66 cents per share on revenue of $1.10 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Ciena shares gained 1.3% to $74.15 in after-hours trading.</li>
<li>Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) posted better-than-expected earnings and sales results for its fourth quarter. The company said it expects first-quarter revenue to be in the range of $5.63 billion to $5.68 billion versus estimates of $5.73 billion. The company anticipates first-quarter adjusted earnings of $4.95 to $5 per share versus estimates of $4.95 per share. Adobe shares dipped 9.2% to $499.48 in the after-hours trading session.</li>
<li>Analysts are expecting Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) to post quarterly earnings at $1.38 per share on revenue of $14.09 billion. The company will release earnings after the markets close. Broadcom shares fell 0.3% to $182.66 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Oxford Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) reported weaker-than-expected earnings and sales results for its third quarter on Wednesday. The company said it now sees FY24 earnings of $6.50 to $6.70 per share, compared to estimates of $7.11 per share. The company projects revenue of $1.5 billion to $1.52 billion versus expectations of $1.52 billion. Oxford Industries shares fell 2.6% to $81.90 in the after-hours trading session.</li>
<li>Analysts expect Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) to post quarterly earnings at $2.59 per share on revenue of $736.35 million after the closing bell. Costco shares fell 0.02% to $994.49 in after-hours trading.</li>
</ul>
Check This Out:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ADBE

AVGO

CIEN

COST

Adobe, Broadcom And 3 Stocks To Watch Heading Into Thursday

<h3>Companies Reporting Before The Bell</h3>
• Live Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVE#NASDAQ">LIVE</a>) is likely to report earnings for its fourth quarter. 
• Lovesac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) is likely to report quarterly loss at $0.28 per share on revenue of $155.26 million. 
• Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) is estimated to report quarterly earnings at $0.65 per share on revenue of $1.10 billion. 
• Lee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEE#NASDAQ">LEE</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $169.88 million. 
• AstroNova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALOT#NASDAQ">ALOT</a>) is expected to report earnings for its third quarter. 
• Liquidity Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) is estimated to report quarterly earnings at $0.28 per share on revenue of $93.05 million. 
<h3>Companies Reporting After The Bell</h3>
• Quanex Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) is estimated to report quarterly earnings at $0.56 per share on revenue of $491.94 million. 
• RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) is projected to report quarterly earnings at $2.64 per share on revenue of $811.81 million. 
• Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) is likely to report quarterly loss at $0.01 per share on revenue of $11.50 million. 
• Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) is projected to report quarterly earnings at $3.79 per share on revenue of $62.08 billion. 
• Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) is estimated to report quarterly earnings at $1.38 per share on revenue of $14.09 billion. 
• Natuzzi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTZ#NYSE">NTZ</a>) is likely to report earnings for its third quarter. 
• Good Times Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTIM#NASDAQ">GTIM</a>) is estimated to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALOT

ELVA

GTIM

LIVE

LOVE

LQDT

Earnings Scheduled For December 12, 2024

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has said that it will be recording an impairment charge of approximately $800 million in the second quarter of fiscal year 2025, according to an SEC filing. This follows General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) <a href="https://www.benzinga.com/tech/24/12/42429588/gms-cruise-exit-draws-sharp-reaction-from-co-founder-kyle-vogt-tesla-ceo-elon-musk-says-autonomous-driving-is-a-very-hard-problem">exit from funding</a> Cruise‘s robotaxi development.
What Happened: General Motors, on Tuesday said that it will no longer fund Cruise‘s robotaxi development but will instead combine the majority-owned unit into its technical teams.
Microsoft announced in January 2021 that it held a minority investment in Cruise, an autonomous vehicle company that is a majority-owned subsidiary of General Motors.
According to Microsoft the impairment charge &#8220;Will be recorded in other income and expense and was not included in our second quarter guidance provided on Oct. 30, 2024. It is estimated to have a negative impact of approximately $0.09 to second quarter diluted earnings per share.&#8221;
General Motors said that the robotaxi development work needs considerable time and resources to scale while adding that the robotaxi market is getting increasingly competitive. The company will now focus on developing its driver assistance technology called Super Cruise which requires active driver supervision, the company said.
See Also: <a href="http://GM's Cruise Exit Draws Sharp Reaction From Co-Founder Kyle Vogt: Tesla CEO Elon Musk Says Autonomous Driving Is A 'Very Hard Problem'">GM&#8217;s Cruise Exit Draws Sharp Reaction From Co-Founder Kyle Vogt: Tesla CEO Elon Musk Says Autonomous Driving Is A &#8216;Very Hard Problem&#8217;</a>
Why It Matters: Bank of America analyst John Murphy believes General Motors' recent decision to prioritize personal autonomous vehicles (AVs) over robotaxi fleets signals a strategic shift, according to a Reuters report. Murphy argues that GM's confidence in the potential of personal AVs stems from the significant capital investment and operational challenges associated with scaling robotaxi fleets.
Garrett Nelson, an analyst at CFRA Research, echoed this sentiment, stating that investors were growing impatient with GM's substantial $10 billion investment in robotaxi development, which had yielded limited tangible results. &#8220;We consider the news a step in the right direction for GM, as we think investors were losing patience with its hefty spending (~$10B) related to robotaxi development with very little to show for its investment,&#8221; reported Reuters.
Elon Musk, Tesla CEO said, "Achieving a general solution to autonomy is a very hard problem, especially doing so without making the car super expensive, suggesting that achieving a cost-effective general solution is a significant challenge. Tesla is focused on enabling autonomous driving through its <a href="https://www.benzinga.com/24/12/42261358/tesla-launches-version-13-of-fsd-but-is-yet-to-achieve-vehicle-autonomy">full self-driving</a> software.
Former Cruise CEO Kyle Vogt, who left the company following an accident involving one of its robotaxis, took to X to criticize GM&#8217;s decision, labeling it as a misguided move.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">In case it was unclear before, it is clear now: GM are a bunch of dummies.
&mdash; Kyle Vogt (@kvogt) <a href="https://twitter.com/kvogt/status/1866612270815494639?ref_src=twsrc%5Etfw">December 10, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42435201/elon-musks-net-worth-surpasses-market-cap-of-us-giants-like-bofa-johnson-johnson-salesforce-chevron-coca-cola-and-more-only-25-companies-have-higher-market-cap">Elon Musk&#8217;s Net Worth Surpasses Market Cap Of US Giants Like BofA, Johnson &amp; Johnson, Salesforce, Chevron, Coca-Cola And More: Only 25 Companies Have Higher Market Cap</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Tech

MSFT

Microsoft Expects $800 Million Impairment Charge Due To GM's Cruise Exit, Analyst Says It's A 'Step In The Right Direction' For Automaker

President-elect Donald Trump is set to ring the New York Stock Exchange opening bell Thursday, just months after threatening to move his company Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) <a href="https://www.benzinga.com/markets/equities/24/12/42447434/democratic-congressman-bought-djt-stock-after-2024-election-months-after-saying-donald-trump-unfit-to-serve">from Nasdaq to NYSE over trading halts</a>.
What Happened: The ceremony comes as DJT stock has surged 107.62% year-to-date, closing at $36.23 on Wednesday with a market capitalization of $7.25 billion.
The former president publicly criticized Nasdaq in September when his company&#8217;s shares faced routine trading halts. &#8220;Why is NASDAQ halting the sale of DJT?&#8221; Trump <a href="https://truthsocial.com/@realDonaldTrump/posts/113132456877184604">wrote</a> on Truth Social. &#8220;I am going to hold NASDAQ, and maybe the SEC, liable for doing what they are doing. If they do it again, we will move the stock to the New York Stock Exchange,&#8221; Trump added.
The stock has seen a volatile performance, with prices ranging from $11.75 to $79.38 over the past 52 weeks. The company&#8217;s shares saw significant movement in September following Trump&#8217;s announcement that he wouldn&#8217;t sell his stake in the company.
<figure class="wp-block-image aligncenter size-large is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12023338/Screenshot-2024-12-12-at-12.59.49%E2%80%AFPM-1-1024x675.png" alt="" class="wp-image-688981" style="width:535px;height:auto" /></figure>
See Also: <a href="https://www.benzinga.com/24/12/42452165/bitcoin-ethereum-dogecoin-spike-after-inflation-data-matches-expectations-top-analyst-foresees-new-btc-ath-if-it-stays-above-this-level">Bitcoin, Ethereum, Dogecoin Spike After Inflation Data Matches Expectations: Top Analyst Foresees New BTC ATH If It Stays Above This Level</a>
Why It Matters: The bell-ringing ceremony carries particular significance as Trump faces legal challenges, including <a href="https://www.benzinga.com/news/legal/24/12/42405278/trump-plays-presidential-immunity-card-in-truth-social-lawsuit-battle">attempts to invoke presidential immunity</a> in a lawsuit against Trump Media &amp; Technology Group. 
Previous presidents, including Ronald Reagan, have used similar NYSE appearances to <a href="https://www.benzinga.com/politics/24/12/42445514/trump-to-open-nyse-thursday-as-markets-surge">promote their economic agenda</a>.
Trump&#8217;s appearance at the exchange comes amid <a href="https://www.benzinga.com/markets/equities/24/12/42452127/nasdaq-breaks-20000-milestone-as-tech-rally-rate-cut-hopes-fuel-market-optimism">broader market optimism</a>, with major indexes reaching record highs following the November election. 
The stock&#8217;s current technical indicators show a Relative Strength Index of 62, suggesting moderate buying momentum as Trump makes his first NYSE bell-ringing appearance.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42452127/nasdaq-breaks-20000-milestone-as-tech-rally-rate-cut-hopes-fuel-market-optimism">Nasdaq Surges Past 20,000 For First Time, Driven By Tech Gains And Rate Cut Hopes</a></li>
</ul>
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Social Media

DJT Stock In Focus As Trump Set To Ring NYSE Bell Today: Here's Why President-Elect Once Threatened To Shift Trump Media From Nasdaq

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4323702-1&amp;h=3355397520&amp;u=https%3A%2F%2Fclarivate.com%2F&amp;a=Clarivate+Plc">Clarivate Plc</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>), a leading global provider of transformative intelligence, today announced the launch of AI Search in Derwent&#x2122;. Combining artificial intelligence (AI) with the premier source of global patent data, Derwent World Patents Index (DWPI)&#x2122;, this solution will enable intellectual property (IP) professionals to make reliable innovation decisions by finding more relevant patents in less time.
&nbsp;
The new AI Search available today in Derwent Innovation uses a language transformer model to understand the context of the input text provided and return relevant results from more than 160 million patent records. It will help patent researchers, patent attorneys and other IP and R&amp;D professionals perform accurate first-pass patentability searches, validate results to ensure relevant records are not missed, and navigate new or unfamiliar technology categories.

CLVT

Clarivate Launches AI-Driven Patent Search Tool In Derwent To Streamline Innovation Decisions

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.juniper.net%2F&amp;esheet=54165308&amp;newsitemid=20241212532821&amp;lan=en-US&amp;anchor=Juniper+Networks&amp;index=1&amp;md5=04497f7f97591bf86b21b72ba02d97f0">Juniper Networks</a>&#xAE;, (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>), a leader in secure, AI-Native Networking, today announced that <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnippongases.com%2F&amp;esheet=54165308&amp;newsitemid=20241212532821&amp;lan=en-US&amp;anchor=Nippon+Gases&amp;index=2&amp;md5=5002a4fe818b04de4ba5d9459c7d19af">Nippon Gases</a>, one of the largest industrial gas companies in Europe, has implemented Juniper's AI-Native wired and wireless LAN solutions to enhance mobile experiences across Nippon Gases's IT and operational technology (OT) environments whilst streamlining network operations to foster digital innovation. As a key element of Juniper's <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.juniper.net%2Fus%2Fen%2Fai-native-networking-platform.html&amp;esheet=54165308&amp;newsitemid=20241212532821&amp;lan=en-US&amp;anchor=AI-Native+Networking+Platform&amp;index=3&amp;md5=121128c98a253372adf65251e9c19732">AI-Native Networking Platform</a>, the new infrastructure uses Mist AI and cloud native capabilities to provide industry-leading efficiency, resiliency and visibility to Nippon Gases, resulting in exceptional user and operator experiences across offices, specialty labs, manufacturing plants, trucks, pipelines and ships.

JNPR

Nippon Gases Deploys Juniper Networks' AI-Native Networking Platform To Boost Mobile Experiences Across Nippon Gases's IT And Operational Technology Environments

Espoo, Finland and Chicago, U.S. - Nokia and <a href="https://www.motorolasolutions.com/en_xu.html?geo=redirect">Motorola Solutions</a> announced a drone technology integration to launch an AI-enhanced turnkey, automated drone-in-a-box solution that sets a new standard for first responders and mission-critical industries, offering enhanced situational awareness, streamlined remote operations, and faster decision-making.

Nokia and Motorola Launch Automated Drone Tech to Boost Emergency Response

Mark Zuckerberg and his company, Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) have made a significant donation of $1 million to support the inauguration events for President-elect Donald Trump. This marks Meta&#8217;s first contribution to an inauguration fund.
What Happened: The donation comes amid efforts by Meta to mend its relationship with Trump, who had previously accused the company of censoring right-wing voices.
Recently, Nick Clegg, Meta&#8217;s head of global affairs, acknowledged that the company might have been overly aggressive in moderating pandemic-related content. This admission is seen as part of Meta&#8217;s strategy to ease tensions with Trump. 
The donation follows a trend among Silicon Valley executives to align with Trump since his election victory, the Financial Times <a href="https://www.ft.com/content/d4c10a1b-425b-4245-ab5a-b396de8232c7">reported</a> on Thursday. 
See Also: <a href="https://www.benzinga.com/24/12/42381987/apple-faces-12b-lawsuit-for-dropping-csam-detection-while-google-and-meta-set-higher-standards-for-child-safety?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Faces $1.2B Lawsuit Over Child Sexual Abuse Material Detection On iCloud — Tech Giant Says, &#8216;Urgently And Actively Innovating&#8217;</a>
Despite a rocky history, including Meta&#8217;s suspension of Trump&#8217;s account following the Capitol riot, Zuckerberg reportedly dined with <a href="https://www.benzinga.com/markets/24/11/42227958/mark-zuckerberg-and-trump-reportedly-met-at-mar-a-lago">Trump at Mar-a-Lago</a>, indicating a potential thaw in their relationship.
Why It Matters: The donation is significant given the recent history between Zuckerberg and Trump. In August, <a href="https://www.benzinga.com/news/24/08/40667286/trump-warns-zuckerberg-in-latest-book-says-he-could-be-in-prison-for-the-rest-of-his-life-we-are-wat">Trump had warned Zuckerberg </a>in his book, suggesting that he could face life imprisonment if he engaged in unlawful activities during the 2024 Presidential Election. This threat highlighted the strained relationship between the two.
However, in December,&nbsp;<a href="https://www.benzinga.com/24/12/42306998/zuckerberg-seeks-active-role-in-trumps-tech-policies-says-metas-president-of-global-affairs-while-admitting-they-overdid-it-a-bit-during-pandemic-content-crackdown">Meta&#8217;s president of global affairs</a>&nbsp;revealed that Zuckerberg is seeking to play an &#8220;active role&#8221; in shaping technology policies under Trump&#8217;s administration. This shift in approach suggests that Meta is keen on influencing tech policies and maintaining its leadership position in the industry.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42378342/intel-stock-is-where-it-was-27-years-ago-how-the-worlds-leading-chipmaker-lost-the-plot-thrice?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Intel Stock Is Where It Was 27 Years Ago: How The World&#8217;s Leading Chipmaker Lost The Plot, Thrice</a></li>
</ul>
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
Image via Wikimedia Commons

Politics

General

Months After Trump Threatened To Put Mark Zuckerberg In Prison, Meta CEO Donates $1M To President-Elect's Inaugural Event

Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that Jiangling Motors Co., Ltd (JMC), a renowned Chinese automotive manufacturer, and Autoliv (Shanghai) Management Co., Ltd, will start a new strategic cooperation to advance innovation and support global expansion.
JMC is a leading company in China's commercial vehicle industry and a new force in the field of passenger vehicles. Autoliv has supplied seatbelts to JMC since 1997.
The new strategic cooperation aims to leverage the companies' respective strengths and enhance global presence together. Efficient supply chain and modularization are expected to create new global market opportunities.

Autoliv and Jiangling Motors Forge Strategic Partnership to Boost Global Automotive Innovation

TAT Technologies Ltd. (TASE: TAT Tech,&nbsp;NASDAQ:&nbsp;TATT), a leading supplier of products and services for the commercial and military aviation industries and the ground defense industries, today announced that it has signed a five-year agreement with a major North American cargo carrier. &nbsp;
Under the terms of the agreement, TAT will provide repair and overhaul services under an MRO agreement for auxiliary power units (APUs) on the Carriers'&nbsp;Boeing 757 and 767 aircraft. The total contract value over the duration of the agreement is estimated at approximately $17 million.

TATT

Reported Earlier, TAT Technologies Secures $17M 5 Year MRO Deal With North American Cargo Carrier For Boeing 757 and 767 APU Services

NUBURU, Inc. ("NUBURU" or the "Company") (NYSE:<a href="https://www.benzinga.com/stock/BURU#NYSE">BURU</a>), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced it received from NYSE Regulation a Warning Letter (the "Letter") as provided under Section 1009(a) of the NYSE American LLC Company Guide (the "Company Guide") describing violations by the Company of Sections 301 and 713 of the Company Guide. Section 301 of the Company Guide prohibits a listed company from issuing, or authorizing its transfer agent or registrar to issue or register, additional securities of a listed class until it has filed an application for the listing of such additional securities and received notification from the NYSE American that the securities have been approved for listing. Section 713 of the Company Guide requires stockholder approval when additional shares to be issued in connection with a transaction involve the sale, issuance, or potential issuance of common stock (or securities convertible into common stock) equal to 20% or more of outstanding stock for less than the greater of book or market value of the stock. As noted in the Letter, the Company issued approximately 4.6 million common shares between May 2024 and August 2024 in connection with the conversion of certain convertible promissory notes that NYSE has determined were in violation of these provisions.
The Company is implementing additional controls to avoid violations of such NYSE rules in the future.

Government

Regulations

BURU

Reported Earlier, NUBURU Addresses NYSE Compliance Violations Over 4.6M Share Issuance

NorthView Acquisition Corporation. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAC#NASDAQ">NVAC</a>) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-Q for the period ended September 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").
This notification has no immediate effect on the listing of the Company's shares on Nasdaq. However, if the Company fails to timely regain compliance with the Nasdaq Listing Rule, the Company's securities will be subject to delisting from Nasdaq.
Under Nasdaq rules, the Company has 60 calendar days to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule. If Nasdaq accepts the Company's plan, then Nasdaq may grant the Company up to 180 days from the prescribed due date for filing the Form 10-Q to regain compliance. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel.
The Company is working diligently and expects to file its Form 10-Q within the 60-day period described above, which would eliminate the need for the Company to submit a formal plan to regain compliance.

NVAC

Reported Earlier, NorthView Acquisition Receives Nasdaq Notice For Dealy In Filing 10-Q

ServiceTitan, Inc. ("ServiceTitan"), the software platform that powers the trades, today announced the pricing of its initial public offering of 8,800,000 shares of its Class A common stock, at a public offering price of $71.00 per share. In addition, ServiceTitan has granted the underwriters a 30-day option to purchase up to an additional 1,320,000 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on December 12, 2024, under the ticker symbol "TTAN." The offering is expected to close on December 13, 2024, subject to customary closing conditions.

IPOs

TTAN

Reported Earlier, ServiceTitan Prices Initial Public Offering Of 8.8M Shares At $71/Share, Will Begin Trading On Nasdaq On December 12

Financial Institutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FISI#NASDAQ">FISI</a>) (the "Company"), parent company of Five Star Bank and Courier Capital, LLC, today announced the pricing of its previously announced underwritten public offering of 4,000,000 shares of its common stock at a public offering price of $25.00 per share. The expected proceeds to the Company, after deducting underwriting discounts and commissions but before deducting operating expenses payable by the Company, are approximately $95.0 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of Company common stock at the public offering price, less underwriting discounts, and commissions.
The Company intends to use the net proceeds from this offering for general corporate purposes which may include a balance sheet restructuring through the repositioning of a substantial portion of our available-for-sale debt securities portfolio to support continued growth as well as the repayment of indebtedness.

Offerings

FISI

Reported Earlier, Financial Institutions Prices $95M Common Stock Offering Of 4M Shares At $25/Share

AmpliTech Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>, AMPGW))) (the "Company"), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with certain institutional investors to purchase 1,352,500 shares of common stock (the "Securities") at an offering price of $1.60 per share, in a registered direct offering.
The gross proceeds to the Company from the registered direct offering are estimated to be approximately $2.2 million before deducting the placement agent's fees and other estimated offering expenses. The offering is expected to close on or about December 13, 2024, subject to the satisfaction of customary closing conditions.

AMPG

Reported Earlier, AmpliTech Prices $2.2M Registered Direct Offering Of 1.35M Shares At $1.60/Share

NewAmsterdam Pharma Company N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>, "NewAmsterdam" or the "Company"))), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease ("CVD") with elevated low-density lipoprotein cholesterol ("LDL-C"), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the pricing of the previously announced underwritten public offering of (i) 12,117,347 of the Company's ordinary shares, nominal value €0.12 per share (the "Ordinary Shares"), at a public offering price of $24.50 per share and (ii) to certain investors that so choose in lieu of Ordinary Shares, pre-funded warrants to purchase 4,882,653 Ordinary Shares at a public offering price of $24.4999 per pre-funded warrant, which represents the per share public offering price for the Ordinary Shares less the $0.0001 per share exercise price for each such pre-funded warrant ("Pre-Funded Warrants," such offering, the "Offering"). The proceeds to the Company from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by the Company, are expected to be approximately $416.5 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 2,550,000 Ordinary Shares at the public offering price, less underwriting discounts and commissions. The Offering is expected to close on or about December 13, 2024, subject to satisfaction of customary closing conditions.

NAMS

Reported Earlier, NewAmsterdam Pharma Prices $416.5M Upsized Public Offering At $24.50/Share  to Advance Cardiovascular Treatments

Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today the pricing of an underwritten public offering of 15,852,886 shares of its Class A common stock, par value $0.01 per share, by Buddy Chester Sub LLC (the "Selling Stockholder"), which is an entity affiliated with funds advised by BC Partners Advisors LP ("BC Partners"), Chewy's largest shareholder (the "Offering"). The Selling Stockholder granted the underwriter a 30-day option to purchase up to an additional 2,377,932 shares of Class A common stock. Chewy will not sell any shares of its Class A common stock in the Offering and will not receive any proceeds from the sale of the shares of Class A common stock being offered by the Selling Stockholder.
In addition, as previously announced, concurrent with the closing of the Offering, Chewy has agreed to purchase from the Selling Stockholder $50 million of Chewy's Class A common stock at a price per share equal to the per share purchase price to be paid by the underwriter in the Offering (the "Concurrent Repurchase"). The Concurrent Repurchase was approved by a special committee of Chewy's Board of Directors, consisting solely of independent and disinterested directors not affiliated with BC Partners. The repurchased shares will be cancelled and retired upon completion of the Concurrent Repurchase. The Concurrent Repurchase is being executed separately from the Company's existing $500 million share repurchase program authorized on May 24, 2024, which will be unaffected by this transaction. The Concurrent Repurchase is expected to be consummated concurrently with the Offering. The Offering is not conditioned upon the closing of the Concurrent Repurchase, but the Concurrent Repurchase is conditioned upon the closing of the Offering.

Buybacks

CHWY

Reported Earlier, Chewy's Largest Shareholder Sells Over 15M Shares in Public Offering, Announces $50M Share Repurchase Concurrent With Major Stock Offering

HUTCHMED (China) Limited ("<a href="https://www.globenewswire.com/Tracker?data=oTcdhXadX19k0ZtVaSkHlIFOWdz_eupbrU5kN4qdyDAEBCFkFGgJtifODWXWuyyWT_Ylh_oU5Si7y6NT9Y1O8g==">HUTCHMED</a>") (Nasdaq/AIM:HCM; HKEX:13) today announces that the Center for Drug Evaluation of China's National Medical Products Administration ("NMPA") has granted Breakthrough Therapy Designation ("BTD") to the combination of ORPATHYS&#xAE; (savolitinib) and TAGRISSO&#xAE; (osimertinib) for the treatment of patients with locally advanced or metastatic epidermal growth factor receptor ("EGFR") mutation‑positive non‑small cell lung cancer ("NSCLC") with MET amplification after disease progression on EGFR inhibitor therapy. ORPATHYS&#xAE; is an oral, potent and highly selective MET tyrosine kinase inhibitor ("TKI"). TAGRISSO&#xAE; is a third-generation, irreversible EGFR TKI.
This treatment combination is being evaluated in China in the ongoing multi-center, open-label, randomized, controlled, Phase III SACHI trial. The study is investigating the efficacy and safety of a combination of ORPATHYS&#xAE; and TAGRISSO&#xAE; compared to platinum-based doublet-chemotherapy (pemetrexed plus cisplatin or carboplatin), the standard‑of‑care treatment option, in patients with locally advanced or metastatic NSCLC with MET amplification after failure of EGFR inhibitor therapy. The primary endpoint of the study is progression-free survival ("PFS") as assessed by investigators. Other endpoints include PFS assessed by an independent review committee, overall survival (OS), objective response rate (ORR), duration of response (DoR), disease control rate (DCR), time to response (TTR), and safety (<a href="https://www.globenewswire.com/Tracker?data=5t4GKVCkKXA8Ab1R2suFdTbevKXKwNJDJuBwPfy8puyY6egl79Z9eui9QHejf_OxruQYkBTlvIEeMjVFcI_Lt1SM-RdlWomkUjUU1sJNRyyPjGTzq7fr-R7Iq2svAB_v">NCT05015608</a>).
NMPA grants BTD to new drugs that treat life-threatening diseases or serious conditions for which there are no effective treatment options, and where clinical evidence demonstrates significant advantages over existing therapies. Drug candidates with BTD may be considered for conditional approval and priority review when submitting an NDA. This indicates that the development and review of the therapy for this disease indication may be expedited, to address patients' unmet needs more quickly.

Reported Earlier, HUTCHMED's ORPATHYS and TAGRISSO Combo Gains Therapy Designation in China for Advanced Lung Cancer

Ormat Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORA#NYSE">ORA</a>) ("Ormat" or the "Company"), a leading geothermal and renewable energy technology company, announced today the pricing of an underwritten secondary offering of 3,700,000 shares of its common stock on behalf of ORIX Corporation. The offering is expected to close on December 13, 2024, subject to customary closing conditions. Ormat is not offering any of its common stock in the offering for its own account and will not receive any proceeds from the sale of the shares being offered by the selling stockholder.
Goldman Sachs &amp; Co. LLC is acting as the sole book-running manager and underwriter for the offering. The shares of common stock are being sold to the public at an initial price of $76.20 per share. Goldman Sachs &amp; Co. LLC will have a 30-day option to purchase up to an additional 555,000 shares of Ormat's common stock from ORIX Corporation.

Reported Earlier, Ormat Selling Stockholder Priced Public Offering of 3.7M Common Stock At $76.20/Share

Nutanix, Inc. ("Nutanix") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) , a leader in hybrid multicloud computing, today announced the pricing of $750 million aggregate principal amount of 0.50% convertible senior notes due 2029 (the "notes") in a private placement (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Nutanix has granted the initial purchasers of the notes an option to purchase up to an additional $112.5 million aggregate principal amount of the notes within a 13-day period from, and including, the initial issuance date of the notes. The sale of the notes to the initial purchasers is expected to settle on December 16, 2024, subject to satisfaction of customary closing conditions.
Nutanix estimates that the net proceeds from the offering will be approximately $734.3 million (or approximately $844.5 million if the initial purchasers exercise their option to purchase additional notes in full), after deducting the initial purchasers' discount and estimated offering expenses payable by Nutanix. Nutanix intends to use (i) approximately $95.5 million of the net proceeds from the offering to repurchase $75.0 million aggregate principal amount of its outstanding 0.25% Convertible Senior Notes due 2027 (the "2027 notes") and (ii) approximately $200.0 million of the net proceeds from the offering to repurchase approximately 3.1 million shares of its Class A common stock, in each case, in privately negotiated transactions effected through one of the initial purchasers of the notes or its affiliates, acting, as Nutanix's agent, at a purchase price per share equal to the closing price of Nutanix's Class A common stock on December 11, 2024, which was $64.78 per share (the "Share Repurchases"). The Share Repurchases will not reduce the amount available for future repurchases under Nutanix's existing share repurchase program. We intend to use the remaining net proceeds of the offering for general corporate purposes, including working capital, capital expenditures and potential acquisitions. From time to time, Nutanix evaluates potential acquisitions of businesses, technologies or products. Currently, however, Nutanix does not have any understandings or agreements with respect to any acquisitions.

NTNX

Reported Earlier, Nutanix Prices $750M 0.50% Convertible Senior Notes Offering

Markets Weekly Outlook - U.S. Dollar's Fate Hinges On NFP As Fed Rate Cut Looms

OPEC Update - November 2024

'Drill, Baby, Drill!'

OPEC+ Meeting In Focus: Will Oil Production Cuts Continue Through March 2025?

Above The Noise: Red Wave, Tariff Uncertainty, And Government Spending

Monthly Newsletter - November 2024

Hurricane Drops U.S. September Oil Production

Why Gold Could Rally In 2025 Despite Recent Weakness

Oil Market Set To Be In Surplus Despite OPEC+ Action

Brent Crude - Oil Prices Rise Despite Largest OPEC Forecast Cuts Of 2024

AAAU

ACTV

AFMC

AFSM

ARKK

AVUV

BAPR

BBCA

BGLD

BOIL

CCRV

CHIQ

CMDY

CNRG

COMB

COMT

CQQQ

CRAK

CXSE

DBEU

DJCB

DRIP

ECNS

EUDG

EWUS

FAAR

FENY

FIBR

FILL

FLAU

FLCA

FLGB

FLMX

FTGC

FTXN

GBBEF

GBIL

GLDI

GLDM

GLTR

GOVT

GOVZ

GRNTF

GUSH

HDRO

HEDJ

HEZU

IAUM

IEUR

IGLD

IVOO

IVOV

JJETF

KOLD

KWEB

LGOV

MAGS

MCHI

MEXX

OILK

OLOXF

OUNZ

PDBC

PHYS

PSCE

RSPG

SCHO

SCHQ

SCHR

SDCI

SGOL

SGOV

SOLR

SPEU

SPLV

SPMD

SPMO

SPMV

SPSM

SPTL

SPTS

SPUS

SPUU

SPVM

SPVU

SPXE

SPXL

SPXN

SPXS

SPXT

SPXU

SPXV

SPYD

SPYG

SPYV

SPYX

SQEW

SQLV

SSPY

SVAL

SYLD

TBJL

TFJL

TMDV

TPHD

TPLC

TPSC

UAUG

UCIB

UJAN

UMAR

UMAY

Comments

(OLOXF) Forecast

(OTC:OLOXF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga